Search

Background: The 2015 American Thyroid Association (ATA) Guidelines recommend the following size cut-offs based on sonographic appearances for subjecting nodules to fine-needle aspiration (FNA) biopsy: low risk: 15 mm and inte rmediate risk and high risk: 10 mm. Objective: We conducted a ‘real-world’ study evaluating the diagnostic performance of the ATA cut-offs against increased thresholds, in the interest of sa fely limiting FNAs. Methods: We performed a retrospective analysis of prospectively collected data on 604 nodules which were sonographically risk-stratified as per th e ATA Guidelines and subsequently subjected to ultrasound-guided FNA. Nodules were c ytologically stratified into ‘benign’ (Bethesda class 2) and ‘non-benign’ (Bethesda cla sses 3–6). We obtained the negative predictive value (NPV), accuracy, FNAs that could be spared, missed ‘non-benign’ cytologies and missed carcinomas on histology, according to the ATA cut-offs compared to higher cut-offs. Results: In low-risk nodules, the high performance of NPV (≈91%) is unaffected by increasing the cut-off to 25 mm, and accuracy improves by 39.4%; 46.8% of FNAs could be spared at the expense of few missed B3–B6 cytologies ( 7.9%) and no missed carcinomas. In intermediate-risk nodules, a 15 mm cut-off increa ses the NPV by 11.3% and accuracy by 40.7%. The spared FNAs approach 50%, while B3–B 6 cytologies are minimal, with no missed carcinomas. In high-risk nodules, low N PV (

Vaccine development against COVID-19 has mitigated severe disease. However, reports of rare but serious adverse events following immunization (sAEFI) in the young populations are fuelling parental anxiety and vaccine hesitancy. With a very early season of viral illnesses including COVID-19, respiratory syncytial virus (RSV), influenza, metapneumovirus and several others, children are facing a winter with significant respiratory illness burdens. Yet, COVID-19 vaccine and booster uptake remain sluggish due to the mistaken beliefs that children have low rates of severe COVID-19 illness as well as rare but severe complications from COVID-19 vaccine are common. In this study we examined composite sAEFI reported in association with COVID-19 vaccines in the United States (US) amongst 5-17-year-old children, to ascertain the composite reported risk associated with vaccination. Between December 13, 2020, and April 13, 2022, a total of 467,890,599 COVID-19 vaccine doses were administered to individuals aged 5-65 years in the US, of which 180 million people received at least 2 doses. In association with these, a total of 177,679 AEFI were reported to the Vaccine Adverse Event reporting System (VAERS) of which 31,797 (17.9%) were serious. The rates of ED visits per 100,000 recipients were 2.56 (95% CI: 2.70-3.47) amongst 5-11-year-olds, 18.25 (17.57-18.95) amongst 12-17-year-olds and 33.74 (33.36-34.13) amongst 18-65-year olds; hospitalizations were 1.07 (95% CI 0.87-1.32) per 100,000 in 5-11-year-olds, 6.83 (6.42-7.26) in 12-17-year olds and 8.15 (7.96-8.35) in 18-65 years; life-threatening events were 0.14 (95% CI: 0.08-0.25) per 100,000 in 5-11-year olds, 1.22 (1.05-1.41) in 12-17-year-olds and 2.96 (2.85-3.08) in 18-65 year olds; and death 0.03 (95% CI 0.01-0.10) per 100,000 in 5-11 year olds, 0.08 (0.05-0.14) amongst 12-17-year olds and 0.76 (0.71-0.82) in 18-65 years age group. The results of our study from national population surveillance data demonstrate rates of reported serious AEFIs amongst 5-17-year-olds which appear to be significantly lower than in 18-65-year-olds. These low risks must be taken into account in overall recommendation of COVID-19 vaccination amongst children.

In this mini-review, we discuss the role of thyroid sonography as a ‘point-of-care’ tool for assessing and managing patients with (suspected) hyperthyroidism who present to the endocrine outpatient clinic. A thyroid ultrasound may aid in distinguishing between hyperthyroidism and destructive thyroiditis. The presence of intense vascularity (‘thyroid inferno’) on the power Doppler has a very high positive predictive value in identifying hyperthyroidism. It may also allow for the sub-classification of hyperthyroidism into autoimmune and nodular hyperthyroidism. It is important to identify the presence of thyroid nodules at an early stage, as this may influence management. Toxic nodules requires definitive treatment, as well as the presence of nodules in Graves’ disease because of increased risk of malignancy. Current guidelines on hyperthyroidism do not clearly state thyroid sonography as a first line investigation, although recent authoritative reviews point in that direction. Given the aforementioned benefits of thyroid sonography, alongside the reduced costs and widespread availability of high-resolution (including portable) ultrasound devices, there is an argument for thyroid sonography to be applied as a first line investigation for all patients with hyperthyroidism. Endocrinologists trained in thyroid sonography could perform this as an extension of their clinical examination when patients first present with hyperthyroidism at the endocrine clinic.

Background: TSH receptor antibody (TRAb) is considered the gold standard diagnostic test for the autoimmunity of Graves’ disease (GD), which is commonly diagnosed clinically. Aim: To evaluate the true positive (sensitivity) and true negative (specificity) rates of clinical diagnosis of GD or non-GD hyperthyroidism compared to the TRAb test. Setting: University teaching hospital in North West England. Participants: Patients in the Endocrinology service who had a TRAb measurement between December 2009 and October 2015. Methods: Electronic patient records were studied retrospectively for a pre-TRAb clinical diagnosis of GD or non-GD hyperthyroidism. We examined descriptive statistics and binary classification tests; Fisher exact test was used to analyse contingency tables. Results: We identified 316 patients with a mean age of 45 (range, 17–89) years; 247 (78%) were women. Compared to the TRAb result, clinical diagnosis had a sensitivity of 88%, specificity 66%, positive predictive value 72%, negative predictive value 84%, false negative rate 12%, false positive rate 34%, positive likelihood ratio 2.6 and negative likelihood ratio 0.2 (P < 0.0001). Conclusions: Clinicians were liable to both over- and under-diagnose GD. The TRAb test can help reduce the number of incorrect or unknown diagnoses in the initial clinical assessment of patients presenting with hyperthyroidism.

ContextMultiple factors contribute to sexual dysfunction in men with obesity. Sex hormone levels are commonly abnormal in men with obesity and this abnormality is often the focus of management in clinical practice. The role of small fibre neuropathy in obesity-related sexual dysfunction is not well established.ObjectiveWe aimed to investigate the relationship between sexual function, sex hormone levels and small nerve fibre morphology in men with severe obesity.Materials and methodsA prospective study of 29 men with severe obesity was undertaken. Sexual function was assessed using the European Male Ageing Study Sexual Function Questionnaire. Small nerve fibre morphology was quantified using corneal confocal microscopy. Sex hormone levels were measured by mass spectrophotometry.ResultsErectile dysfunction was present in 72% of the cohort with a higher prevalence of diabetes among the symptomatic group (88% vs 38%, p = 0.006). Corneal nerve fibre length (CNFL) and corneal nerve fibre density (CNFD) were both significantly lower in participants with erectile dysfunction compared to those without (p = 0.039 and p = 0.048 respectively). The erectile function score correlated with CNFL (r = -0.418, p = 0.034) and CNFD (r = -0.411, p = 0.037). Total testosterone and calculated free testosterone levels did not differ significantly between men with or without erectile dysfunction (median 8.8 nmol/L vs 9.0 nmol/L, p = 0.914; and median 176 pmol/L vs 179 pmol/L, p = 0.351 respectively), infrequent sexual thoughts (median 8.1 nmol/L vs 9.2 nmol/L, p = 0.650; and median 184 pmol/L, vs 176 pmol/L, p = 0.619 respectively) and decreased morning erections (median 9.0 nmol/L vs 8.8 nmol/L, p = 0.655; and median 170 pmol/L vs 193 pmol/L, p = 0.278 respectively).ConclusionSexual dysfunction is highly prevalent in men with severe obesity. We found an association between small fibre neuropathy with erectile dysfunction with presence of diabetes a likely a significant contributing factor. We found no associations between testosterone levels with sexual symptoms (including frequency of sexual thoughts). The influence of small nerve fibre neuropathy on response to therapeutic interventions and whether interventions that improve small fibre neuropathy can improve erectile function in this population merits further study.

Background Bariatric surgery is the most effective treatment for severe obesity. There can be variation in the degree of weight reduction following bariatric surgery. It is unknown whether single nucleotide polymorphisms (SNPs) in the glucocorticoid receptor locus (GRL) affect postoperative weight loss and metabolic outcomes.Materials/methods We studied the association between selected candidate SNPs and postoperative weight loss and metabolic outcomes in patients with severe obesity undergoing bariatric surgery. The polymorphisms rs41423247 (Bcl1), rs56149945 (N363S) and rs6189/rs6190 (ER22/23EK) were analysed.Results The 139 participants included 95 women (68.3%) and had a median (interquartile range) age of 53.0 (46.0–60.0) years and mean (SD) weight of 140.8 (28.8) kg and body mass index of 50.3 (8.6) kg/m2. At baseline, 59 patients had type 2 diabetes (T2D), 60 had hypertension and 35 had obstructive sleep apnoea syndrome treated with continuous positive airway pressure (CPAP). 84 patients (60.4%) underwent gastric bypass and 55 (39.6%) underwent sleeve gastrectomy. There were no significant differences in weight loss, glycated haemoglobin (HbA1c) or lipid profile categorized by genotype status, sex or median age. There was significant weight reduction after bariatric surgery with a postoperative BMI of 34.1 (6.8) kg/m2 at 24 months (p

Thyroid dysfunction is the commonest endocrine disorder in pregnancy apart from diabetes. Thyroid hormones are essential for fetal brain development in the embryonic phase. Maternal thyroid dysfunction during pregnancy may have significant adverse maternal and fetal outcomes such as preterm delivery, preeclampsia, miscarriage and low birth weight. In this review we discuss the effect of thyroid disease on pregnancy and the current evidence on the management of different thyroid conditions in pregnancy and postpartum to improve fetal and neonatal outcomes, with special reference to existing guidelines on the topic which we dissect, critique and compare with each other. Overt hypothyroidism and hyperthyroidism should be treated appropriately in pregnancy, aiming to maintain euthyroidism. Subclinical hypothyroidism is often pragmatically treated with levothyroxine, although it has not been definitively proven whether this alters maternal or fetal outcomes. Subclinical hyperthyroidism does not usually require treatment and the possibility of non-thyroidal illness or gestational thyrotoxicosis should be considered. Autoimmune thyroid diseases tend to improve during pregnancy but commonly flare-up or emerge in the post-partum period. Accordingly, thyroid auto-antibodies tend to decrease with pregnancy progression. Postpartum thyroiditis should be managed based on the clinical symptoms rather than abnormal biochemical results.

PurposeObesity is a major modifiable risk factor for cardiovascular disease. Bariatric surgery is considered to be the most effective treatment option for weight reduction in obese patients with and without type 2 diabetes (T2DM).ObjectiveTo evaluate changes in lipoproteins, insulin resistance, mediators of systemic and vascular inflammation, and endothelial dysfunction following Roux-en-Y bariatric surgery in obese patients with and without diabetes.Materials and methodsLipoproteins, insulin resistance, mediators of systemic and vascular inflammation, and endothelial dysfunction were measured in 37 obese patients with (n = 17) and without (n = 20) T2DM, before and 6 and 12 months after Roux-en-Y bariatric surgery. Two way between subject ANOVA was carried out to study the interaction between independent variables (time since surgery and presence of diabetes) and all dependent variables.ResultsThere was a significant effect of time since surgery on (large effect size) weight, body mass index (BMI), waist circumference, triglycerides (TG), small-dense LDL apolipoprotein B (sdLDL ApoB), HOMA-IR, CRP, MCP-1, ICAM-1, E-selectin, P-selectin, leptin, and adiponectin. BMI and waist circumference had the largest impact of time since surgery. The effect of time since surgery was noticed mostly in the first 6 months. Absence of diabetes led to a significantly greater reduction in total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol although the effect size was small to medium. There was a greater reduction in TG and HOMA-IR in patients with diabetes with a small effect size. No patients were lost to follow up.ConclusionLipoproteins, insulin resistance, mediators of systemic and vascular inflammation, and endothelial dysfunction improve mostly 6 months after bariatric surgery in obese patients with and without diabetes.Clinical Trial Registrationwww.ClinicalTrials.gov, identifier: NCT02169518. https://clinicaltrials.gov/ct2/show/NCT02169518?term=paraoxonase&cntry1=EU%3AGB&rank=1.

Twelve spectrophotometric methods based on new reactions for the determination of trace amounts of nitrite in environmental samples were developed. Replacement of toxic reagents was explored to attain the standards of clean chemistry. These methods utilize two classes of compounds namely; phytochemicals and sulfonamides, in the presence of limited amounts of sodium hydroxide. The methods were based on the oxidation of sulfanilamide (SAA), sulfadoxine (SDX), sulfamethoxazole (SMX) or sulfadiazine (SDZ) by nitrite in sodium hydroxide medium and coupling with cardol, cardanol or anacardic acid which yielded yellow, orange and orange red color derivatives having an absorbance maximum in the range 430, 460 and 470 nm, respectively. The colors developed were stable for about 3 h. Beer’s law was obeyed for nitrite in the concentration range 0.08–0.90, 0.16–1.04, 0.08–0.80 and 0.08–0.80 μg ml−1 for cardol; 0.80–4.40, 1.60–5.72, 0.52–5.20 and 0.80–4.40 μg ml−1 for cardanol and 0.80–5.70, 1.04–6.20, 1.30–5.20 and 0.80–4.00 μg ml−1 for anacardic acid, respectively. The reaction conditions and other important analytical parameters were optimized to enhance the sensitivity of the methods. Interference if any, by non-target ions was also investigated. The methods were applied determining nitrite in environmental samples. The performances of these methods were evaluated in terms of Student’s t-test and variance ratio F-test to find out the significance of the proposed methods over the reference spectrophotometric method.

Nylon 6 is extensively used in engineering applications because of its unique characteristics such as low price, low viscosity, high toughness, shelf lubricating behaviour and high chemical resistance. Nanocomposites based on PA-6 were prepared by melt extrusion and an adjacent injection moulding process. Mechanical and thermomechanical properties have been investigated by tensile testing and dynamic mechanical analysis. To evaluate the potential of crysnano nanoclays as a new candidate in the class of nanofillers, the properties of the crysnano nanoclays nanocomposites has been compared to those of glass fiber. Thermal characteristics were performed using thermogravimetric analysis (TGA), differential scanning calorimetry (DSC) and dynamic mechanical analysis (DMA). With increase in filler loading, the enthalpy of melting (Hm) obtained from DSC curves was reduced as compared to pristine nylon 6. All the nanocompsoites were stable upto 205 °C. Degradation kinetic parameters have been calculated for thermal degradation processes using the composites using three mathematical models, namely Horowitz–Metzger, Coats–Redfern and Broido’s methods.

The study proposed the removal of Brilliant Green, a cationic dye, by adsorption process from wastewater solution utilizing a low-cost adsorbent such as Nutraceutical Industrial Pepper Seed Spent (NIPSS). The study comprises an investigation of the parametric influence on the adsorption process. The parameters identified are pH, dye concentration, process temperature, quantity of the adsorbent, and particle size. The study of statistics found from experiments was carried out by incorporating Freundlich, Brouers-Sotolongo, Langmuir, Toth, Sips, Jovanovic, and Redlich-Peterson isotherm models. The adsorption kinetics were determined by implementing pseudo-first-order and second-order models, diffusion film models, and Dumwald-Wagner and Weber-Morris models. The experimental adsorption capacity qe was found to be about 130 mg/g. This value was closest to the maximum adsorption of 144.6mg/g predicted by the Brouers-Sotolongo isotherm which had a correlation coefficient (R2) of 0.998. The adsorption kinetics data was confirmed to be a pseudo-second-order model. The change in free energy, enthalpy change, and entropy change were vital thermodynamic factors in concluding that adsorption is almost spontaneous and endothermic process. Change in enthalpy (ΔH°) reduced value indicates the physical nature of the process. The adsorption of BG dye on the adsorbent surface was authenticated by FTIR spectroscopy and SEM imaging. A Central Composite Design (CCD) Quadratic model under Response Surface Methodology (RSM) was implemented for statistical optimization of adsorption capacity for the five parameters studied, namely, time, temperature, concentration of the dye, weight of the adsorbent, and pH. Software Design Expert 7.0 was used to evaluate 3D contour plots. The process of optimization yielded a value of 350 mg/g. Thus, incrementing the adsorption process by 84.2 %. The study provides insights on various dye and adsorbent interaction possibilities and derives that NIPSS is an efficient adsorbent to extract BG dye from wastewater solutions.

The aim of this study is to discover the potential use of nutraceutical industrial cumin seed spent (NICUS) as an economical biosorbent for eliminating acid blue 113 (AB113), an azo dye, from water. The study investigates the influence of pH, adsorbent dosage, temperature, particle size, and initial dye concentration on the adsorption of AB113. Various isotherm models and kinetic models were studied. At equilibrium situations, the maximum trial adsorption volume (qe) was found to be 96 mg g−1. The main objective was to determine the suitability of the pseudo-second-order model for describing the kinetics of adsorption. Thermodynamic parameters ΔG0 ΔH0 ΔS0 revealed that the adsorption process was endothermic and non-spontaneous. The lower value of ΔH0 suggests a physical adsorption process. Analysis using FTIR and SEM spectra confirmed that the NICUS surface effectively adsorbed AB113. NICUS emerges as a promising adsorbent for the efficient deduction of AB113 from aqueous solutions.

Abstract Research studies have been carried out to accentuate Fennel Seed Spent, a by-product of the Nutraceutical Industry, as an inexpensive, recyclable and operational biosorbent for bioremediation of Acid Blue 113 (AB113) in simulated water-dye samples and textile industrial effluent (TIE). The physical process of adhesion of AB113 on the surface of the biosorbent depends on various parameters, such as the initial amount of the dye, amount and expanse of the biosorbent particles, pH of the solution and temperature of the medium. The data obtained was analyzed using three two-parameter and five three-parameter adsorption isotherm models to glean the adsorbent affinities and interaction mechanism of the adsorbate molecules and adsorbent surface. The adsorption feature study is conducted employing models of Weber-Morris, pseudo 1st and 2nd order, diffusion film model, Dumwald-Wagner and Avrami model. The study through 2nd order pseudo and Avrami models produced complementary results for the authentication of experimental data. The thermodynamic features, ΔG 0 , ΔH 0, and ΔS 0 of the adsorption process are acclaimed to be almost spontaneous, physical in nature and endothermic in their manifestation. Surface characterization was carried out using Scanner Electron Microscopy, and identification and determination of chemical species and molecular structure was performed using Infrared Spectroscopy (IR). Maximum adsorption evaluated using statistical optimization with different combinations of five independent variables to study the individual as well as combined effects by Fractional Factorial Experimental Design (FFED) was 236.18 mg g−1 under optimized conditions; pH of 2, adsorbent dosage of 0.500 g L−1, and an initial dye concentration of 209.47 mg L−1 for an adsorption time of 126.62 min with orbital shaking of 165 rpm at temperature 49.95 °C.

Abstract Background Obesity poses significant challenges to healthcare globally, particularly through its bi‐directional relationship with co‐morbid metabolic conditions such as type 2 diabetes and hypertension. There is also emerging evidence of an association between obesity and chronic kidney disease (CKD) which is less well characterized. Methods A literature search of electronic libraries was conducted to identify and present a narrative review of the interplay between obesity and CKD. Findings Obesity may predispose to CKD directly as it is linked to the histopathological finding of obesity‐related glomerulopathy and indirectly through its widely recognized complications such as atherosclerosis, hypertension, and type 2 diabetes. The biochemical and endocrine products of adipose tissue contribute to pathophysiological processes such as inflammation, oxidative stress, endothelial dysfunction, and proteinuria. The prevention and management of obesity may prove critical in counteracting both the development and advancement of CKD. Moreover, measures of abdominal adiposity such as waist circumference, are generally associated with worse morbidity and mortality in individuals receiving maintenance hemodialysis. Conclusion Obesity is a risk factor for the onset and progression of CKD and should be recognized as a potential target for a preventative public health approach to reduce CKD rates within the general population. Future research should focus on the use of glucagon‐like peptide‐1 receptor agonists and sodium–glucose cotransporter 2 inhibitors in patients with CKD and obesity due to their multi‐faceted actions on major outcomes.

ObjectiveTo analyze rates of reported severe adverse events after immunization (sAEFI) attributed to SARS-CoV-2 vaccines in the United States (US) using safety surveillance data.MethodsObservational study of sAEFI reported to the vaccine adverse events reporting system (VAERS) between December 13, 2020, to December 13, 2021, and attributed to SARS-CoV-2 vaccination programs across all US states and territories. All sAEFI in conjunction with mRNA (BNT-162b2 or mRNA-1273) or adenovector (Ad26.COV2.S) vaccines were included. The 28-day crude cumulative rates for reported emergency department (ED) visits and sAEFI viz. hospitalizations, life-threatening events and deaths following SARS-CoV-2 vaccination were calculated. Incidence rate ratios (IRRs) of reported sAEFI were compared between mRNA and adenovector vaccines using generalized Poisson regression models.ResultsDuring the study period, 485 million SARS-CoV-2 vaccines doses were administered nationwide, and 88,626 sAEFI reported in VAERS. The 28-day crude cumulative reporting rates per 100,000 doses were 14.97 (95% confidence interval, 14.86–18.38) for ED visits, 5.32 (5.26–5.39) for hospitalizations, 1.72 (1.68–1.76) for life-threatening events, and 1.08 (1.05–1.11) for deaths. Females had two-fold rates for any reported AEFI compared to males, but lower adjusted IRRs for sAEFI. Cumulative rates per dose for reported sAEFI attributed to adenovector vaccine were 2–3-fold higher, and adjusted IRRs 1.5-fold higher than mRNA vaccines.ConclusionsOverall cumulative rates for reported sAEFI following SARS-CoV-2 vaccination in the US over 1 year were very low; single-dose adenovector vaccine had 1.5-fold higher adjusted rates for reported sAEFI, which may however equate with multiple-doses mRNA vaccine regimens. These data indicate absence of high risks of sAEFI following SARS-CoV-2 vaccines and support safety equipoise between mRNA and adenovector vaccines. Public health messaging of these data is critical to overcome heuristic biases. Furthermore, these data may support ongoing adenovector vaccine use, especially in low- and middle-income countries due to affordability, logistical and cold chain challenges.

Abstract Obesity and associated dyslipidemia may contribute to increased cardiovascular disease. Obesity has also been associated with neuropathy. We have investigated presence of peripheral nerve damage in patients with severe obesity without type 2 diabetes and the status of metabolic syndrome and lipoprotein abnormalities. 47participants with severe obesity and 30 age-matched healthy controls underwent detailed phenotyping of neuropathy and an assessment of lipoproteins and HDL-functionality. Participants with severe obesity had a higher neuropathy symptom profile, lower sural and peroneal nerve amplitudes, abnormal thermal thresholds, heart rate variability with deep breathing and corneal nerve parameters compared to healthy controls. Circulating apolipoprotein A1 (P = 0.009), HDL cholesterol (HDL-C) (P

Abstract The present study reports about the use of fenugreek seed spent as a new and efficient biosorbent for the removal of acid blue 113 dye from aqueous media and textile industrial effluent. The spent is a low-cost by-product of nutraceutical industry. The effects of various process parameters of adsorption, such as pH, initial dye concentration, adsorbent dose, adsorbent particle size, contact time and temperature onto nutraceutical industrial fenugreek seed spent (NIFGS) have been studied. Four numbers of two-parameter and six numbers of three-parameter isotherm models were used in the analysis of adsorption equilibrium data. Kinetic studies data conformed to pseudo-second-order model. Molecular diffusion studies were carried out using Weber–Morris, Dumwald–Wagner and film diffusion models. Change in enthalpy (ΔH°), entropy change (ΔS°) and Gibbs free energy change (ΔG°) of adsorption system indicated that the process is physisorption. Scanning electron microscopy, Fourier transform infrared spectroscopy and point of zero charge were used in characterizing the adsorbent. Fractional factorial experimental design and analysis of variance along with statistically developed model for adsorption helped to predict for a maximum adsorption of 661.5 mg g−1 using NIFGS. Application of NIFGS to textile industrial effluent and scaling up of the experimental process by three orders gave encouraging results.

The economic viability of adsorbing crystal violet (CV) using pepper seed spent (PSS) as a biosorbent in an aqueous solution has been studied. A parametrical investigation was conducted considering parameters like initial concentration of dye, time of contact, pH value, and temperature variation. The analysis of experimental data obtained was carried out by evaluating with the isotherms of Freundlich, Sips, Tempkin, Jovanovic, Brouers–Sotolongo, Toth, Vieth–Sladek, Radke–Prausnitz, Langmuir, and Redlich–Peterson. The adsorption kinetics were studied by implementing the Dumwald-Wagner, Weber-Morris, pseudo-first-order, pseudo-second-order, film diffusion, and Avrami models. The experimental value of adsorption capacity (Qm=129.4 mg g−1) was observed to be quite close to the Jovanovic isotherm adsorption capacity (Qm=82.24 mg g−1) at (R2), coefficient of correlation of 0.945. The data validation was found to conform to that of pseudo-second-order and Avrami kinetic models. The adsorption process was specified as a spontaneous and endothermic process owing to the thermodynamic parametrical values of ΔG0, ΔH0, and ΔS0. The value of ΔH0 is an indicator of the process’s physical nature. The adsorption of CV to the PSS was authenticated from infrared spectroscopy and scanning electron microscopy images. The interactions of the CV-PSS system have been discussed, and the observations noted suggest PSS as a feasible adsorbent to extract CV from an aqueous solution.

Roux-en-Y gastric bypass (RYGB) is one of the most commonly performed weight-loss procedures, but how severe obesity and RYGB affect circulating HDL-associated microRNAs (miRNAs) remains unclear. Here, we aim to investigate how HDL-associated miRNAs are regulated in severe obesity and how weight loss after RYGB surgery affects HDL-miRNAs. Plasma HDLs were isolated from patients with severe obesity (n = 53) before and 6 and 12 months after RYGB by immunoprecipitation using goat anti-human apoA-I microbeads. HDLs were also isolated from 18 healthy participants. miRNAs were extracted from isolated HDL and levels of miR-24, miR-126, miR-222, and miR-223 were determined by TaqMan miRNA assays. We found that HDL-associated miR-126, miR-222, and miR-223 levels, but not miR-24 levels, were significantly higher in patients with severe obesity when compared with healthy controls. There were significant increases in HDL-associated miR-24, miR-222, and miR-223 at 12 months after RYGB. Additionally, cholesterol efflux capacity and paraoxonase activity were increased and intercellular adhesion molecule-1 (ICAM-1) levels decreased. The increases in HDL-associated miR-24 and miR-223 were positively correlated with an increase in cholesterol efflux capacity (r = 0.326, P = 0.027 and r = 0.349, P = 0.017, respectively). An inverse correlation was observed between HDL-associated miR-223 and ICAM-1 at baseline. Together, these findings show that HDL-associated miRNAs are differentially regulated in healthy participants versus patients with severe obesity and are altered after RYGB. These findings provide insights into how miRNAs are regulated in obesity before and after weight reduction and may lead to the development of novel treatment strategies for obesity and related metabolic disorders.

This research reports the first-ever study on abundantly available, environmentally friendly, low-cost and ready-for-use Nutraceutical Industrial Cumin Seed Spent (NICUS) as an innovative adsorbent for bioremediation of a bisazo Acid Red 119 (AR119) dye, a probable mutagen from textile industrial effluents (TIEs). The experiment at the laboratory scale is designed to suit the concepts of sustainability and valorisation under the domain of circular economy. The experimental qe value obtained was 96.00 mg g−1. The optimised conditions of parameters are as follows: pH of 2; adsorption time, 210 min; adsorbent dosage, 0.300 g L−1; particle size, 175 µM; initial dye concentration, 950 mg L−1; orbital shaking, 165 rpm and temperature, 50 °C, producing an impressive value of 748 mg of dye adsorbing on 1 g of dry NICUS. The adsorption capacity of NICUS obtained from the quadratic model developed for process optimisation gave values of 748 mg g−1. As a prelude to commercialisation, five variables that affect the adsorption process were experimentally studied. For the feasibility and efficiency of the process, a two-level fractional factorial experimental design (FFED) was applied to identify variables that influence the adsorption capacity of NICUS. The identified variables were applied to scale experiments by three orders. Nine isotherm models were used to analyse the adsorption equilibrium data. The Vieth–Sladek adsorption isotherm model was found to be the best fit. The pseudo-second-order reaction was the appropriate mechanism for the overall rate of the adsorption process. Mechanistic studies related to mass transfer phenomena were more likely to be dominant over the diffusion process. Techniques such as SEM, FTIR and CHN analysis were used to characterise NICUS. The dye-adsorbed NICUS obtained as “sludge” was used as a reinforcing material for the fabrication of composites using plastic waste. The physicomechanical and chemical properties of thermoplastic and thermoset composite using dye-adsorbed NICUS were evaluated and compared with NICUS composites. Prospects of integrating Small and Medium Enterprises (SMEs) into the circular economy of Nutraceutical Industrial Spent (NIS) are discussed.

Severe obesity is a disease associated with multiple adverse effects on health. Metabolic bariatric surgery (MBS) can have significant effects on multiple body systems and was shown to improve inflammatory markers in previous short-term follow-up studies. We evaluated associations between changes in inflammatory markers (CRP, IL6 and TNFα) and circulating proteins after MBS. Methods: Sequential window acquisition of all theoretical mass spectra (SWATH-MS) proteomics was performed on plasma samples taken at baseline (pre-surgery) and 6 and 12 months after MBS, and concurrent analyses of inflammatory/metabolic parameters were carried out. The change in absolute abundances of those proteins, showing significant change at both 6 and 12 months, was tested for correlation with the absolute and percentage (%) change in inflammatory markers. Results: We found the following results: at 6 months, there was a correlation between %change in IL-6 and fold change in HSPA4 (rho = −0.659; p = 0.038) and in SERPINF1 (rho = 0.714, p = 0.020); at 12 months, there was a positive correlation between %change in IL-6 and fold change in the following proteins—LGALS3BP (rho = 0.700, p = 0.036), HSP90B1 (rho = 0.667; p = 0.05) and ACE (rho = 0.667, p = 0.05). We found significant inverse correlations at 12 months between %change in TNFα and the following proteins: EPHX2 and ACE (for both rho = −0.783, p = 0.013). We also found significant inverse correlations between %change in CRP at 12 months and SHBG (rho = −0.759, p = 0.029), L1CAM (rho = −0.904, p = 0.002) and AMBP (rho = −0.684, p = 0.042). Conclusion: Using SWATH-MS, we identified several proteins that are involved in the inflammatory response whose levels change in patients who achieve remission of T2DM after bariatric surgery in tandem with changes in IL6, TNFα and/or CRP. Future studies are needed to clarify the underlying mechanisms in how MBS decreases low-grade inflammation.

Simple, sensitive and selective spectrophotometric methods were developed for the determination of five antiulcer drugs namely, omeprazole (OMZ), lansoprazole (LNZ), pantoprazole (PNZ), rabeprazole (RBZ) and esomeprazole (EMZ) using neocuproine or bathocuproine as reagents. The reaction is based on the reduction of copper(II) to copper(I) by OMZ, LNZ, PNZ, RBZ and EMZ which subsequently reacts with neocuproine or bathocuproine in neutral medium to produce yellow or orange-red coloured complex with maximum absorbance at 460 or 480 nm, respectively. Beer's law was obeyed in the concentration range 0.2-4.0 μg mL-1 with a relative standard deviation ranging between 0.5-1.0 and 0.5-1.1 for the drugs with neocuproine and bathocuproine, respectively. The limits of detection were found to be 0.007-0.024 and 0.01-0.026 μg mL-1 and the limits of quantification ranged between 0.019-0.067 and 0.026-0.062 µg mL-1 with neocuproine and bathocuproine, respectively. The optimum assay conditions were investigated and the accuracy was found to be 99.3-100.5 % and 99.1-100.7 %, while the correlation coefficients ranged between 0.9830-1.0213 and 0.9896-0.9981 with neocuproine and bathocuproine, respectively. The colour developed was stable for 24 h at room temperature (~ 27 oC). The commonly encountered excipients and additives did not interfere in the determination. Results obtained by this method for the pure drugs and commercial tablets agreed well with those obtained by reported method.